Metformin Eql

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformin Eql (Metformin Hydrochloride)

Q: What is Metformin Eql used for?

Metformin Eql is an oral biguanide indicated for the management of type 2 diabetes mellitus. It helps lower blood glucose levels by improving insulin sensitivity and reducing hepatic glucose production, thereby assisting patients in achieving glycaemic targets.

Q: How does Metformin work in the body?

Metformin activates AMP‑activated protein kinase (AMPK), which suppresses liver glucose output, reduces intestinal glucose absorption, and enhances peripheral tissue uptake of glucose. These combined effects lower fasting and post‑prandial blood sugar without directly stimulating insulin release.

Q: What is the usual dose of Metformin Eql?

The appropriate dose of Metformin Eql is determined by the prescribing clinician based on individual patient factors such as renal function, glycaemic control, and tolerability. Dosage adjustments are made during treatment to achieve optimal blood glucose levels.

Q: Is Metformin Eql safe during pregnancy or breastfeeding?

The safety of Metformin Eql in pregnancy and lactation has not been definitively established. Clinicians weigh potential benefits against risks and may consider alternative therapies. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

Q: How do I order Metformin Eql from GNH India?

To place an order, submit an enquiry on the Metformin Eql product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Q: How does Metformin Eql compare with other antidiabetic drugs?

Metformin Eql belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, and SGLT2 inhibitors. Unlike insulin‑secretagogues, metformin does not cause hypoglycaemia when used alone and is often first‑line therapy because of its efficacy, weight‑neutral profile, and cardiovascular benefits.

Q: What are the recommended storage conditions for Metformin Eql?

Metformin Eql should be stored at ambient temperature, below 25 °C (77 °F). Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Q: How is Metformin Eql administered?

Metformin Eql is taken orally, usually with meals to minimise gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

Q: What are the most serious risks associated with Metformin Eql?

The most serious adverse reaction is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or acute illness. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Q: Who should not use Metformin Eql?

Metformin Eql is contraindicated in individuals with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, and in patients receiving iodinated contrast studies without adequate hydration.

Metformin, the active ingredient in Metformin Eql, is a biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood glucose control.

GNH India supplies Metformin Eql as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Eql Pharma Ab

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin Eql belongs to the biguanide class and is used to manage disorders of glucose metabolism.

Type 2 diabetes mellitus: improves glycaemic control and reduces HbA1c levels.
Prediabetes (impaired fasting glucose): may be prescribed to lower the risk of progression to type 2 diabetes.
Polycystic ovary syndrome (off‑label): can help improve insulin resistance when used under specialist supervision.

How It Works

Metformin reduces hepatic gluconeogenesis, decreases intestinal absorption of glucose, and enhances peripheral insulin sensitivity by activating AMP‑activated protein kinase (AMPK). These actions collectively lower fasting plasma glucose and improve overall glycaemic control without stimulating insulin secretion.

Side Effects

Metformin Eql may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

Nausea: mild to moderate stomach upset.
Diarrhoea: loose stools, often early in therapy.
Abdominal discomfort: cramping or bloating.
Metallic taste: transient after dosing.
Loss of appetite: reduced desire to eat.
Flatulence: increased gas production.

Serious or Rare Side Effects

Lactic acidosis: a rare but life‑threatening metabolic disturbance.
Severe skin reactions: such as Stevens‑Johnson syndrome.
Hepatic failure: marked liver enzyme elevation.
Hypoglycaemia: uncommon when used alone.
Pancreatitis: inflammation of the pancreas.
Persistent vomiting: may lead to dehydration.

Precautions & Warnings

Metformin Eql requires careful monitoring in several clinical situations.

Renal function assessment: avoid use in severe renal impairment (eGFR <30 mL/min/1.73 m²).
Hepatic function monitoring: contraindicated in acute liver disease.
Vitamin B12 surveillance: long‑term therapy may reduce B12 levels.
Elderly patients: start at lower dose and titrate slowly.
Alcohol consumption: limit intake to reduce lactic acidosis risk.
Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Metformin Eql can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
Cimetidine: can raise metformin plasma concentrations.
Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

Beta‑blockers: may mask hypoglycaemic symptoms.
Thiazide diuretics: can increase plasma glucose levels.
ACE inhibitors: may affect renal function, requiring closer monitoring.

Frequently Asked Questions

Metformin Eql is an oral biguanide indicated for the management of type 2 diabetes mellitus. It helps lower blood glucose levels by improving insulin sensitivity and reducing hepatic glucose production, thereby assisting patients in achieving glycaemic targets.

Metformin activates AMP‑activated protein kinase (AMPK), which suppresses liver glucose output, reduces intestinal glucose absorption, and enhances peripheral tissue uptake of glucose. These combined effects lower fasting and post‑prandial blood sugar without directly stimulating insulin release.

The appropriate dose of Metformin Eql is determined by the prescribing clinician based on individual patient factors such as renal function, glycaemic control, and tolerability. Dosage adjustments are made during treatment to achieve optimal blood glucose levels.

The safety of Metformin Eql in pregnancy and lactation has not been definitively established. Clinicians weigh potential benefits against risks and may consider alternative therapies. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the Metformin Eql product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metformin Eql belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, and SGLT2 inhibitors. Unlike insulin‑secretagogues, metformin does not cause hypoglycaemia when used alone and is often first‑line therapy because of its efficacy, weight‑neutral profile, and cardiovascular benefits.

Metformin Eql should be stored at ambient temperature, below 25 °C (77 °F). Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Metformin Eql is taken orally, usually with meals to minimise gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious adverse reaction is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or acute illness. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformin Eql is contraindicated in individuals with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, and in patients receiving iodinated contrast studies without adequate hydration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 05 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.